Archundia GA, Hurtado RD, Díaz QG, Ixcamparij RC, Blanco CM, Mae HA, González RE, Sánchez CR

Idioma: Español
Referencias bibliográficas: 21
Paginas: 231-236
Archivo PDF: 70.80 Kb.

RESUMEN

El trasplante del corazón es una modalidad de tratamiento poco frecuente en la cardiopatía congénita avanzada. Se presenta el caso de un joven de 17 años portador de una tetralogía de Fallot dilatada y en fase terminal a quien se hizo trasplante ortotópico del corazón; se presentan los datos más relevantes de su manejo a los 53 meses de postoperatorio y se discute la perspectiva a largo plazo, que es comparable a la esperada en los enfermos trasplantados por otros padecimientos cardiacos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Starnes VA, Stinson EB, Oyer PE, Valantine H, Baldwin JC, Hunt SA, et al: Cardiac transplantation in children and adolescents. Circulation 1987; 76(5 Pt 2): V43-7.

2. Menkis AH, McKenzie FN, Novick RJ, Kostuk WJ, Pflugfelder PW, Goldbach M, et al: Special considerations for heart transplantation in congenital heart disease. The Pediatric Heart Transplant Group. J Heart Transplant 1990; 9(6): 602-7.

3. Fowler BM, Vagelos Randair: Evaluating and selecting patients for cardiac transplantation. In: Smith AJ, McCarthy PM, Sarris EG, Stinson BE, Reitz AB (Eds.) The Stanford Manual of Cardiopulmonary Transplantation. New York. Future Publishing Co. 1996: 3-4.

4. Control sanitario de la disposición de órganos, tejidos, células y cadáveres de seres humanos. En: Ley General de Salud. Editorial Porrúa. México 1997; Tomo 1: 63-66.

5. O’Connell BJ, Bourge CR, Costanzo-Nordin M, Driscoll JD, Morgan PJ, Rose AE, et al: Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992; 86(3): 1061-78.

6. Jeevanendam V, Barr ML, Auteri JS, Sánchez JA, Ott GY, Schenkel FA, et al: University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation: a randomized blinded prospective clinical trial. J Thorac Cardiovasc Surg 1992; 103: 194-9.

7. Rowlatt JF, Rimoldi JHA, Lev M: The quantitative anatomy of the normal childs heart. Pediatric Clin North Am 1963; 10: 499-504.

8. Snider AR, Enderlein MA, Teitel DF, Juster RP: Two-dimensional echocardiography determinations of aortic and pulmonary artery sizes from infancy to adulthood in normal subjects. Am J Cardiol 1984; 53: 218-225.

9. Billingham ME: Diagnosis of cardiac rejection by endocardial biopsy. Heart Transplant 1982; 1: 25-30.

10. Speziali G, Driscoll DJ, Danielson GK, Julsrud PR, Porter CJ, Dearani JA, et al: Cardiac transplantation for end-stage congenital heart defects: the Mayo Clinic experience. Mayo Cardiothoracic Transplant Team. Mayo Clin Proc 1998; 73(10): 923-8.

11. Rygg IH, Olesen K, Boesen I: The life history of tetralogy of Fallot. Dan Med Bull 1971; 18(suppl II): 25-30.

12. Hurts JW, Spann JF: Etiology and clinical recognition of heart failure. In: Hust JW (Ed). The heart arteries and veins. 3ª. Ed. New York, McGraw-Hill Book Co 1966: 448-449.

13. Kirklin JW, Barrat-Boyes GB: Cardiac Surgery. New York. Churchil Livingstone, 1993: 884-885.

14. Petronio AS, Manes MT, Di Meco F, Nardini V, Pecori F, Ceccherini-Nellis L, et al: Etiopathogenesis of dilated cardiomyopathies. Cardiologia 1993; 38(suppl 1): 267-76.

15. Pentimone F, Mechelli S, Riccioni S, Del Corso L: Longevity in tetralogy of fallot. The natural history of a 63-year-old man living without surgery. Minerva Cardioangiol 1992; 40(7-8): 279-84.

16. Lamour JM, Addonizio LJ, Galantowicz ME, Quaegebeur JM, Mancini DM, Kichuk MR, et al: Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation 1999; 100(19 Suppl): II200-5.

17. Cooper M, Fuzesi L, Addonizio L, Hsu D, Smith C, Rose E: Heart transplantation after operations involving the pulmonary arteries. J Thorac Cardiovasc Surg 1991; 102: 386-395.

18. Johnson DE, Gao SZ, Schroeder J: The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 1989; 8: 349-53.

19. McDonald K, Rector TS, Braunlin EA: Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64: 359-63.

20. Grattan MT, Moreno-Cabral CE, Starnes VA: Eight-year results of cyclosporine-treated patient with cardiac transplants. J Thorac Cardiovasc Surg 1990; 99: 500-509.

21. Haverich A: Cyclosporine in heart transplantation. Transpl Proc 1992; 24(suppl 2): 82-84.